Media-OutReach Newswire Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in highly debilitating autoinflammatory diseases
Media-OutReach Newswire Coface Asia Corporate Payment Survey 2023: Asian companies experience fewer payment delays and are rather optimistic despite multiple headwinds ahead